| Daniel E Hrad, MD | |
|
4205 Westbrook Dr, Aurora, IL 60504-4124 | |
| (630) 527-1818 | |
| (630) 527-1244 |
| Full Name | Daniel E Hrad |
|---|---|
| Gender | Male |
| Speciality | Family Practice |
| Experience | 25 Years |
| Location | 4205 Westbrook Dr, Aurora, Illinois |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1033166921 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | 036105603 (Illinois) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Dupage Medical Group Ltd | 5496667941 | 1209 |
News Archive
For non-depressed, pregnant women with histories of major depressive disorder, preventive treatment with antidepressants may not necessarily protect against postpartum depression, according to new UCLA research.
With the public fretting about rising health costs and deepening federal budget deficits, White House officials, including budget director Peter Orszag, were quick last week to trumpet the optimism of some economists who said the Senate's version of health reform would help control costs, the San Francisco Chronicle reports.
Alan Hirsch, MD, founder and neurologic director of the Smell & Taste Treatment and Research Foundation, presented his research on Odor-Induced Pseudodystonia at the 3rd International Congress on Gait and Mental Function in Washington, D.C. on February 27.
Skin cancer, particularly melanoma, which is the deadliest and most serious type of human skin cancer, begins as a small lesion or blemish. Usually, these blemishes start off as harmless accumulation of melanocytes, which give the skin its color. As the disease progresses, it can spread throughout the body.
Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that a therapy that would improve median overall survival over IFL (bolus 5-fluorouracil, generics/leucovorin, generics/irinotecan*) plus bevacizumab (Roche/Genentech/Chugai's Avastin), would earn a 60 percent patient share in stage IV colorectal cancer, according to surveyed U.S. oncologists. In Europe, such an agent would earn a 50 percent patient share, according to surveyed European oncologists.
› Verified 8 days ago
| Entity Name | Dupage Medical Group Ltd |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1801833983 PECOS PAC ID: 5496667941 Enrollment ID: O20031110000535 |
News Archive
For non-depressed, pregnant women with histories of major depressive disorder, preventive treatment with antidepressants may not necessarily protect against postpartum depression, according to new UCLA research.
With the public fretting about rising health costs and deepening federal budget deficits, White House officials, including budget director Peter Orszag, were quick last week to trumpet the optimism of some economists who said the Senate's version of health reform would help control costs, the San Francisco Chronicle reports.
Alan Hirsch, MD, founder and neurologic director of the Smell & Taste Treatment and Research Foundation, presented his research on Odor-Induced Pseudodystonia at the 3rd International Congress on Gait and Mental Function in Washington, D.C. on February 27.
Skin cancer, particularly melanoma, which is the deadliest and most serious type of human skin cancer, begins as a small lesion or blemish. Usually, these blemishes start off as harmless accumulation of melanocytes, which give the skin its color. As the disease progresses, it can spread throughout the body.
Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that a therapy that would improve median overall survival over IFL (bolus 5-fluorouracil, generics/leucovorin, generics/irinotecan*) plus bevacizumab (Roche/Genentech/Chugai's Avastin), would earn a 60 percent patient share in stage IV colorectal cancer, according to surveyed U.S. oncologists. In Europe, such an agent would earn a 50 percent patient share, according to surveyed European oncologists.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Daniel E Hrad, MD Po Box 713260, Chicago, IL 60677-1260 Ph: (630) 469-9200 | Daniel E Hrad, MD 4205 Westbrook Dr, Aurora, IL 60504-4124 Ph: (630) 527-1818 |
News Archive
For non-depressed, pregnant women with histories of major depressive disorder, preventive treatment with antidepressants may not necessarily protect against postpartum depression, according to new UCLA research.
With the public fretting about rising health costs and deepening federal budget deficits, White House officials, including budget director Peter Orszag, were quick last week to trumpet the optimism of some economists who said the Senate's version of health reform would help control costs, the San Francisco Chronicle reports.
Alan Hirsch, MD, founder and neurologic director of the Smell & Taste Treatment and Research Foundation, presented his research on Odor-Induced Pseudodystonia at the 3rd International Congress on Gait and Mental Function in Washington, D.C. on February 27.
Skin cancer, particularly melanoma, which is the deadliest and most serious type of human skin cancer, begins as a small lesion or blemish. Usually, these blemishes start off as harmless accumulation of melanocytes, which give the skin its color. As the disease progresses, it can spread throughout the body.
Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that a therapy that would improve median overall survival over IFL (bolus 5-fluorouracil, generics/leucovorin, generics/irinotecan*) plus bevacizumab (Roche/Genentech/Chugai's Avastin), would earn a 60 percent patient share in stage IV colorectal cancer, according to surveyed U.S. oncologists. In Europe, such an agent would earn a 50 percent patient share, according to surveyed European oncologists.
› Verified 8 days ago
Joseph Robert Rojas, Family Medicine Medicare: Medicare Enrolled Practice Location: 2020 Ogden Ave, Aurora, IL 60504 Phone: 630-978-4850 Fax: 630-978-6865 | |
Jurate Kunickaite, DO Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 2285 Sequoia Dr, Aurora, IL 60506 Phone: 630-859-6859 | |
Aruna Galla-pagadala, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 2285 Sequoia Dr, Aurora, IL 60506 Phone: 630-859-6700 | |
Kuchipudi Veerraju, MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 475 N Farnsworth Ave, Aurora Medical Clinic, Aurora, IL 60505 Phone: 630-898-0022 Fax: 630-898-2933 | |
Dr. Robert D. Paras, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 2111 Ogden Ave, Aurora, IL 60504 Phone: 630-978-3800 Fax: 630-862-3085 | |
Dr. Mona Habiba Waheed, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 2285 Sequoia Dr, Aurora, IL 60506 Phone: 630-859-6700 |